SMTL ID : 3gi2.1

Human dihydrofolate reductase Q35K mutant inhibitor complex

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.53 Å

Oligo State

monomer

Ligands

1 x GHW: N-({4-[(2-amino-6-methyl-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-5-yl)sulfanyl]phenyl}carbonyl)-L-glutamic acid(Non-covalent)

GHW.1: 18 residues within 4Å: Chain A: I.8, V.9, A.10, L.23, E.31, F.32, R.33, F.35, K.36, T.57, I.61, N.65, L.68, R.71, V.116, Y.122, T.137 Ligands: NDP.2 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:F.32, A:F.32, A:F.35, A:T.57 Hydrogen bonds: A:N.65, A:T.137, A:T.137 Water bridges: A:E.31, A:E.31, A:K.69 Salt bridges: A:E.31, A:K.36, A:K.36, A:R.71 pi-Stacking: A:F.35

1 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.2: 28 residues within 4Å: Chain A: V.9, A.10, I.17, G.18, K.19, G.21, D.22, L.23, W.25, G.54, K.55, K.56, T.57, S.60, L.76, S.77, R.78, E.79, R.92, S.93, V.116, G.118, S.119, V.121, Y.122, E.124, T.147 Ligands: GHW.1 34 PLIP interactions: 34 interactions with chain A Hydrophobic interactions: A:T.57 Hydrogen bonds: A:A.10, A:I.17, A:K.19, A:G.21, A:G.21, A:K.55, A:K.56, A:T.57, A:S.60, A:S.77, A:R.78, A:E.79, A:E.79, A:L.94, A:G.118, A:S.119, A:E.124 Water bridges: A:K.55, A:K.55, A:K.55, A:K.56, A:K.56, A:G.118, A:S.119, A:S.119, A:S.120, A:S.120, A:S.120, A:S.120, A:S.120, A:E.124 Salt bridges: A:K.55, A:K.56

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gangjee, A. et al., Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents. J.Med.Chem. (2009)

Release Date

2009-09-29

Peptides

Dihydrofolate reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dihydrofolate reductase

Related Entries With Identical Sequence